[O26-3] O26-3: Pharmacogenomics (1)

[O26-3-1] Tacrolimus updated guidelines through population-based pharmacokinetics modeling: how to benefit more from CYP3A pre-emptive genotyping prior to kidney transplantation

Laure Elens¹, Jean-Baptiste Woillard², Michael Neely³, Arnaud Capron⁴, Ron Van Schaik⁵, Teun van Gelder⁶, Dennis Hesselink⁷, Nuria Lloberas⁸, Pierre Marquet⁹, Vincent Haufroid¹⁰ (1.Universite catholique de Louvain, 2.CHU limoges, 3.Children’s Hospital Los Angeles, 4.Universite catholique de Louvain, 5.University Medical Centre Rotterdam, 6.University Medical Center Rotterdam, 7.University Medical Center Rotterdam, 8.University of Barcelona, 9.CHU Limoges, 10.Universite catholique de Louvain)

Keywords:Dosage guidelines, Population pharmacokinetics, Tacrolimus, kidney transplantation, Pharmacogenetics